GlassScriptPhysician profile
Susan J Windham
NPI 1184783482
$621.27
in general payments reported to CMS, 2019-2025
14 companies · $13.66 in 2025
The $13.66 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $246 · 2023: $24.50 · 2024: $18.25 · 2025: $13.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $202.68 | 2021-2022 | |
| Convatec INC. | $56.77 | 2022 | |
| Astellas Pharma US INC | $51.16 | 2021 | |
| Allergan, INC. | $48.57 | 2021 | |
| Coloplast Corp | $46.67 | 2021-2025 | |
| Axonics, INC. | $42.75 | 2023-2024 | Axonics |
| Myovant Sciences INC. | $33.62 | 2021 | |
| Urovant Sciences INC | $31.26 | 2021-2022 | |
| Abbvie INC. | $24.03 | 2022 | |
| Blue Earth Diagnostics | $22.05 | 2021 | |
| Progenics Pharmaceuticals, INC. | $18.37 | 2022 | |
| Janssen Biotech, INC. | $15.99 | 2021 | |
| Pfizer INC. | $13.70 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Windham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.